ReP USP - Resultado da busca

Artigo de periodico
Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters (2022)
Crippa, José Alexandre de Souza ; Pereira Junior, Luiz C.; Pereira, Lívia C.; Zimmermann, Patrícia M.; Brum Júnior, Liberato; Rechia, Letícia Mello; Dias, Isabella Caroline da Silva; Hallak, Jaime Eduardo Cecilio ; Campos, Alline Cristina de; Guimarães, Francisco Silveira ; Queiroz, Regina Helena Costa; Zuardi, Antonio Waldo
Fonte: Brazilian Journal of Psychiatry. Unidades: FMRP, FCFRP
Assuntos: CANABINOIDES, FARMACOTERAPIA, FARMACODINÂMICA, MÉTODO DUPLO-CEGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters. Brazilian Journal of Psychiatry, v. 44, n. 1, p. 15-20, 2022Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2020-1684. Acesso em: 11 nov. 2024.
APA
Crippa, J. A. de S., Pereira Junior, L. C., Pereira, L. C., Zimmermann, P. M., Brum Júnior, L., Rechia, L. M., et al. (2022). Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters. Brazilian Journal of Psychiatry, 44( 1), 15-20. doi:10.1590/1516-4446-2020-1684
NLM
Crippa JA de S, Pereira Junior LC, Pereira LC, Zimmermann PM, Brum Júnior L, Rechia LM, Dias IC da S, Hallak JEC, Campos AC de, Guimarães FS, Queiroz RHC, Zuardi AW. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters [Internet]. Brazilian Journal of Psychiatry. 2022 ; 44( 1): 15-20.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/1516-4446-2020-1684
Vancouver
Crippa JA de S, Pereira Junior LC, Pereira LC, Zimmermann PM, Brum Júnior L, Rechia LM, Dias IC da S, Hallak JEC, Campos AC de, Guimarães FS, Queiroz RHC, Zuardi AW. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters [Internet]. Brazilian Journal of Psychiatry. 2022 ; 44( 1): 15-20.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/1516-4446-2020-1684
Artigo de periodico
Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion (2022)
Corrêa, Márcio da Silveira; Freitas, Betânia Souza de; Machado, Gustavo Dalto Barroso; Pires, Vivian Naziaseno; Bromberg, Elke; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza ; Schröder, Nadja
Fonte: Behavioural Brain Research. Unidade: FMRP
Assuntos: ESTRÓGENOS, CANABINOIDES, MEMÓRIA, OVARIECTOMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORRÊA, Márcio da Silveira et al. Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion. Behavioural Brain Research, v. 417, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2021.113555. Acesso em: 11 nov. 2024.
APA
Corrêa, M. da S., Freitas, B. S. de, Machado, G. D. B., Pires, V. N., Bromberg, E., Hallak, J. E. C., et al. (2022). Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion. Behavioural Brain Research, 417. doi:10.1016/j.bbr.2021.113555
NLM
Corrêa M da S, Freitas BS de, Machado GDB, Pires VN, Bromberg E, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion [Internet]. Behavioural Brain Research. 2022 ; 417[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.bbr.2021.113555
Vancouver
Corrêa M da S, Freitas BS de, Machado GDB, Pires VN, Bromberg E, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion [Internet]. Behavioural Brain Research. 2022 ; 417[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.bbr.2021.113555
Artigo de periodico
Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli (2022)
Abichabki, Nathália de Lima Martins ; Zacharias, Luísa Vieira; Moreira, Natália Columbaro; Bellíssimo-Rodrigues, Fernando; Moreira, Fernanda L.; Benzi, Jhohann Richard de Lima ; Ogasawara, Tânia Mara Casare; Ferreira, Joseane Cristina; Ribeiro, Camila M.; Pavan, Fernando R.; Pereira, Leonardo Régis Leira; Brancini, Guilherme Thomaz Pereira; Braga, Gilberto Ubida Leite; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Lanchote, Vera Lucia ; Cantón, Rafael; Darini, Ana Lúcia da Costa ; Andrade, Leonardo Neves de
Fonte: Scientific Reports. Unidades: FMRP, FCFRP
Assuntos: CANABINOIDES, REPOSICIONAMENTO DE FÁRMACOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, SINERGISMO DE DROGAS, TESTES DE SENSIBILIDADE MICROBIANA, BACTÉRIAS GRAM-NEGATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABICHABKI, Nathália de Lima Martins et al. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, v. 12, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-10393-8. Acesso em: 11 nov. 2024.
APA
Abichabki, N. de L. M., Zacharias, L. V., Moreira, N. C., Bellíssimo-Rodrigues, F., Moreira, F. L., Benzi, J. R. de L., et al. (2022). Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, 12, 1-15. doi:10.1038/s41598-022-10393-8
NLM
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Vancouver
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Artigo de periodico
Cannabidiol for the treatment of autism spectrum disorder: hope or hype? (2022)
Pedrazzi, João Francisco Cordeiro; Ferreira, Frederico Rogério; Amaral, Danyelle Silva; Lima, Daniel Antunes; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Del Bel, Elaine Aparecida ; Guimarães, Francisco Silveira ; Costa, Karla Cristinne Mancini ; Campos, Alline Cristina de; Crippa, Ana C. S.; Crippa, José Alexandre de Souza
Fonte: Psychopharmacology. Unidades: FMRP, FORP
Assuntos: ANTIPSICÓTICOS, FARMACOTERAPIA, CANABINOIDES, CRIANÇAS EM IDADE PRÉ-ESCOLAR, TRANSTORNO DO DEFICIT DE ATENÇÃO COM HIPERATIVIDADE, TRANSTORNO DO ESPECTRO AUTISTA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?. Psychopharmacology, v. 239, n. 9, p. 2713-2734, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00213-022-06196-4. Acesso em: 11 nov. 2024.
APA
Pedrazzi, J. F. C., Ferreira, F. R., Amaral, D. S., Lima, D. A., Hallak, J. E. C., Zuardi, A. W., et al. (2022). Cannabidiol for the treatment of autism spectrum disorder: hope or hype? Psychopharmacology, 239( 9), 2713-2734. doi:10.1007/s00213-022-06196-4
NLM
Pedrazzi JFC, Ferreira FR, Amaral DS, Lima DA, Hallak JEC, Zuardi AW, Del Bel EA, Guimarães FS, Costa KCM, Campos AC de, Crippa ACS, Crippa JA de S. Cannabidiol for the treatment of autism spectrum disorder: hope or hype? [Internet]. Psychopharmacology. 2022 ; 239( 9): 2713-2734.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s00213-022-06196-4
Vancouver
Pedrazzi JFC, Ferreira FR, Amaral DS, Lima DA, Hallak JEC, Zuardi AW, Del Bel EA, Guimarães FS, Costa KCM, Campos AC de, Crippa ACS, Crippa JA de S. Cannabidiol for the treatment of autism spectrum disorder: hope or hype? [Internet]. Psychopharmacology. 2022 ; 239( 9): 2713-2734.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s00213-022-06196-4
Artigo de periodico
Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder (2022)
Bolsoni, Lívia Maria; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Guimarães, Francisco Silveira ; Zuardi, Antonio Waldo
Fonte: Psychopharmacology. Unidade: FMRP
Assuntos: ANSIEDADE, FARMACOTERAPIA, CANABINOIDES, TRANSTORNOS DA ANSIEDADE, TRANSTORNO DO STRESS PÓS-TRAUMÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOLSONI, Lívia Maria et al. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder. Psychopharmacology, v. 239, n. 5, p. 1499-1507, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00213-021-06043-y. Acesso em: 11 nov. 2024.
APA
Bolsoni, L. M., Crippa, J. A. de S., Hallak, J. E. C., Guimarães, F. S., & Zuardi, A. W. (2022). Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder. Psychopharmacology, 239( 5), 1499-1507. doi:10.1007/s00213-021-06043-y
NLM
Bolsoni LM, Crippa JA de S, Hallak JEC, Guimarães FS, Zuardi AW. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder [Internet]. Psychopharmacology. 2022 ; 239( 5): 1499-1507.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s00213-021-06043-y
Vancouver
Bolsoni LM, Crippa JA de S, Hallak JEC, Guimarães FS, Zuardi AW. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder [Internet]. Psychopharmacology. 2022 ; 239( 5): 1499-1507.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s00213-021-06043-y
Artigo de periodico
Cannabidiol for rapid eye movement sleep behavior disorder (2021)
Almeida, Carlos Mauricio Oliveira de ; Brito, Manuelina Mariana Capellari Macruz; Bosaipo, Nayanne Beckman ; Pimentel, Angela Vieira; Tumas, Vitor ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Eckeli, Alan Luiz
Fonte: Movement Disorders. Unidade: FMRP
Assuntos: CANABINOIDES, DOENÇA DE PARKINSON, TRANSTORNOS DO SONO, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Carlos Mauricio Oliveira de et al. Cannabidiol for rapid eye movement sleep behavior disorder. Movement Disorders, v. 36, n. 7, p. 1711-1715, 2021Tradução . . Disponível em: https://doi.org/10.1002/mds.28577. Acesso em: 11 nov. 2024.
APA
Almeida, C. M. O. de, Brito, M. M. C. M., Bosaipo, N. B., Pimentel, A. V., Tumas, V., Zuardi, A. W., et al. (2021). Cannabidiol for rapid eye movement sleep behavior disorder. Movement Disorders, 36( 7), 1711-1715. doi:10.1002/mds.28577
NLM
Almeida CMO de, Brito MMCM, Bosaipo NB, Pimentel AV, Tumas V, Zuardi AW, Crippa JA de S, Hallak JEC, Eckeli AL. Cannabidiol for rapid eye movement sleep behavior disorder [Internet]. Movement Disorders. 2021 ; 36( 7): 1711-1715.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/mds.28577
Vancouver
Almeida CMO de, Brito MMCM, Bosaipo NB, Pimentel AV, Tumas V, Zuardi AW, Crippa JA de S, Hallak JEC, Eckeli AL. Cannabidiol for rapid eye movement sleep behavior disorder [Internet]. Movement Disorders. 2021 ; 36( 7): 1711-1715.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/mds.28577
Artigo de periodico
Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study (2021)
Gaya, Carolina de Meneses; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Miguel, André Q.; Laranjeira, Ronaldo; Bressan, Rodrigo Affonseca; Zuardi, Antonio Waldo; Lacerda, Acioly Luiz Tavares
Fonte: Brazilian Journal of Psychiatry. Unidade: FMRP
Assuntos: COCAÍNA, CANABINOIDES, TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS, DEPENDENTES QUÍMICOS, MÉTODO DUPLO-CEGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GAYA, Carolina de Meneses et al. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study. Brazilian Journal of Psychiatry, v. 43, n. 5 , p. 467-476, 2021Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2020-1416. Acesso em: 11 nov. 2024.
APA
Gaya, C. de M., Crippa, J. A. de S., Hallak, J. E. C., Miguel, A. Q., Laranjeira, R., Bressan, R. A., et al. (2021). Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study. Brazilian Journal of Psychiatry, 43( 5 ), 467-476. doi:10.1590/1516-4446-2020-1416
NLM
Gaya C de M, Crippa JA de S, Hallak JEC, Miguel AQ, Laranjeira R, Bressan RA, Zuardi AW, Lacerda ALT. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 5 ): 467-476.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/1516-4446-2020-1416
Vancouver
Gaya C de M, Crippa JA de S, Hallak JEC, Miguel AQ, Laranjeira R, Bressan RA, Zuardi AW, Lacerda ALT. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 5 ): 467-476.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/1516-4446-2020-1416
Artigo de periodico
Increased body sway in phobic patients exposed to images of spiders (2021)
Linares, Ila Marques Porto; Nardi, Antonio E.; Guimarães, Francisco Silveira ; Arrais, Kátia C.; Chagas, Marcos Hortes Nisihara ; Osório, Flávia de Lima ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Coimbra, Norberto Cysne ; Crippa, José Alexandre de Souza
Fonte: Brazilian Journal of Psychiatry. Unidade: FMRP
Assuntos: ANSIEDADE, TRANSTORNOS DA ANSIEDADE, FOBIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LINARES, Ila Marques Porto et al. Increased body sway in phobic patients exposed to images of spiders. Brazilian Journal of Psychiatry, v. 43, n. 5, p. 477-483, 2021Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2020-1466. Acesso em: 11 nov. 2024.
APA
Linares, I. M. P., Nardi, A. E., Guimarães, F. S., Arrais, K. C., Chagas, M. H. N., Osório, F. de L., et al. (2021). Increased body sway in phobic patients exposed to images of spiders. Brazilian Journal of Psychiatry, 43( 5), 477-483. doi:10.1590/1516-4446-2020-1466
NLM
Linares IMP, Nardi AE, Guimarães FS, Arrais KC, Chagas MHN, Osório F de L, Hallak JEC, Zuardi AW, Coimbra NC, Crippa JA de S. Increased body sway in phobic patients exposed to images of spiders [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 5): 477-483.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/1516-4446-2020-1466
Vancouver
Linares IMP, Nardi AE, Guimarães FS, Arrais KC, Chagas MHN, Osório F de L, Hallak JEC, Zuardi AW, Coimbra NC, Crippa JA de S. Increased body sway in phobic patients exposed to images of spiders [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 5): 477-483.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/1516-4446-2020-1466
Artigo de periodico
Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors (2021)
Pereira, Anamaria Falcão; Lisboa, Mario Roberto Pontes; Alves, Bruno Wesley de Freitas; Silva, Cristiane Maria Pereira da; Dias, Diego Bernarde Souza; Menezes, Karoline Luanne Santos; Cesário, Francisco Rafael Alves Santana; França, Jonas Costa de; Oliveira, Amanda Rocha de; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza ; Alencar, Nylane Maria Nunes de; Lima Júnior, Roberto Cesar Pereira; Vale, Mariana Lima
Fonte: Neurotoxicity Research. Unidade: FMRP
Assuntos: GÂNGLIOS ESPINHAIS, NOCICEPTIVIDADE, ANTINEOPLÁSICOS, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Anamaria Falcão et al. Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors. Neurotoxicity Research, v. 39, n. 6, p. 1782-1799, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12640-021-00442-x. Acesso em: 11 nov. 2024.
APA
Pereira, A. F., Lisboa, M. R. P., Alves, B. W. de F., Silva, C. M. P. da, Dias, D. B. S., Menezes, K. L. S., et al. (2021). Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors. Neurotoxicity Research, 39( 6), 1782-1799. doi:10.1007/s12640-021-00442-x
NLM
Pereira AF, Lisboa MRP, Alves BW de F, Silva CMP da, Dias DBS, Menezes KLS, Cesário FRAS, França JC de, Oliveira AR de, Hallak JEC, Zuardi AW, Crippa JA de S, Alencar NMN de, Lima Júnior RCP, Vale ML. Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors [Internet]. Neurotoxicity Research. 2021 ; 39( 6): 1782-1799.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s12640-021-00442-x
Vancouver
Pereira AF, Lisboa MRP, Alves BW de F, Silva CMP da, Dias DBS, Menezes KLS, Cesário FRAS, França JC de, Oliveira AR de, Hallak JEC, Zuardi AW, Crippa JA de S, Alencar NMN de, Lima Júnior RCP, Vale ML. Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors [Internet]. Neurotoxicity Research. 2021 ; 39( 6): 1782-1799.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s12640-021-00442-x
Artigo de periodico-carta/editorial
Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] (2021)
Pacheco, Júlia Cozar; Souza, José Diogo dos Santos; Hallak, Jaime Eduardo Cecilio ; Osório, Flávia de Lima ; Campos, Alline Cristina de; Guimarães, Francisco Silveira ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza
Fonte: Journal of Clinical Psychopharmacology. Unidade: FMRP
Assuntos: CANABINOIDES, ANTICONVULSIVANTES, COVID-19, ESTRESSE PROFISSIONAL, SAÚDE MENTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PACHECO, Júlia Cozar et al. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/JCP.0000000000001405. Acesso em: 11 nov. 2024. , 2021
APA
Pacheco, J. C., Souza, J. D. dos S., Hallak, J. E. C., Osório, F. de L., Campos, A. C. de, Guimarães, F. S., et al. (2021). Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1097/JCP.0000000000001405
NLM
Pacheco JC, Souza JD dos S, Hallak JEC, Osório F de L, Campos AC de, Guimarães FS, Zuardi AW, Crippa JA de S. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 327-329.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1097/JCP.0000000000001405
Vancouver
Pacheco JC, Souza JD dos S, Hallak JEC, Osório F de L, Campos AC de, Guimarães FS, Zuardi AW, Crippa JA de S. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 327-329.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1097/JCP.0000000000001405
Artigo de periodico
Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13 (2021)
Falvella, Ana Caroline Brambilla; Smith, Bradley Joseph; Silva-Costa, Licia C.; Valença, Aline G. F.; Crunfli, Fernanda; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Almeida, Valéria de; Martins-de Souza, Daniel
Fonte: Frontiers in Molecular Neuroscience. Unidade: FMRP
Assuntos: ESQUIZOFRENIA, ANTIPSICÓTICOS, LINHAGEM CELULAR, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FALVELLA, Ana Caroline Brambilla et al. Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13. Frontiers in Molecular Neuroscience, v. 14, 2021Tradução . . Disponível em: https://doi.org/10.3389/fnmol.2021.673144. Acesso em: 11 nov. 2024.
APA
Falvella, A. C. B., Smith, B. J., Silva-Costa, L. C., Valença, A. G. F., Crunfli, F., Zuardi, A. W., et al. (2021). Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13. Frontiers in Molecular Neuroscience, 14. doi:10.3389/fnmol.2021.673144
NLM
Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JEC, Crippa JA de S, Almeida V de, Martins-de Souza D. Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13 [Internet]. Frontiers in Molecular Neuroscience. 2021 ; 14[citado 2024 nov. 11 ] Available from: https://doi.org/10.3389/fnmol.2021.673144
Vancouver
Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JEC, Crippa JA de S, Almeida V de, Martins-de Souza D. Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13 [Internet]. Frontiers in Molecular Neuroscience. 2021 ; 14[citado 2024 nov. 11 ] Available from: https://doi.org/10.3389/fnmol.2021.673144
Artigo de periodico
Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? (2021)
Loss, Cássio Morais; Teodoro, Lucas; Rodrigues, Gabriela Doná; Moreira, Lucas Roberto; Peres, Fernanda Fiel; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Abilio, Vanessa Costhek
Fonte: Frontiers in Pharmacology. Unidade: FMRP
Assuntos: CANABINOIDES, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, TRANSTORNO AUTÍSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOSS, Cássio Morais et al. Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders?. Frontiers in Pharmacology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.635763. Acesso em: 11 nov. 2024.
APA
Loss, C. M., Teodoro, L., Rodrigues, G. D., Moreira, L. R., Peres, F. F., Zuardi, A. W., et al. (2021). Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? Frontiers in Pharmacology, 11. doi:10.3389/fphar.2020.635763
NLM
Loss CM, Teodoro L, Rodrigues GD, Moreira LR, Peres FF, Zuardi AW, Crippa JA de S, Hallak JEC, Abilio VC. Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? [Internet]. Frontiers in Pharmacology. 2021 ; 11[citado 2024 nov. 11 ] Available from: https://doi.org/10.3389/fphar.2020.635763
Vancouver
Loss CM, Teodoro L, Rodrigues GD, Moreira LR, Peres FF, Zuardi AW, Crippa JA de S, Hallak JEC, Abilio VC. Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? [Internet]. Frontiers in Pharmacology. 2021 ; 11[citado 2024 nov. 11 ] Available from: https://doi.org/10.3389/fphar.2020.635763

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Título da fonte

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada